Dupont

Azul 3D, Inc. is a manufacturer of advanced 3D printers, specializing in High-Area Rapid Printing (HARP) technology. Founded in 2016 and based in Skokie, Illinois, the company focuses on producing large objects quickly and efficiently, offering a solution that bridges the gap between prototyping and mass manufacturing. The HARP technology converts liquid plastic into solid forms, allowing for the production of both single, large parts and multiple smaller components simultaneously. By utilizing a diverse range of consumer and industrial-grade plastics, Azul 3D aims to provide a streamlined and cost-effective manufacturing process, making it competitive with traditional methods like injection molding.

Laird Performance Materials is a world leader in high-performance electromagnetic shielding and thermal management with a comprehensive offering of performance components and solutions that manage heat and protect devices from electromagnetic interference.

OxyMem solves energy intensive wastewater treatment with an innovative ‘Drop in’ solution for wastewater aeration, the Membrane Aerated Biofilm Reactor (MABR). OxyMem MABR complements existing treatment systems and delivers up to 50% additional biological capacity in an existing aeration or alternatively enables you to replace a legacy system. Conventional wastewater treatment consumes 2-3% of a nation’s electricity production. This is due a 100 years reliance on bubble diffusion for conventional treatment plants which will typically suffer energy losses of 65-70% in the process because of the oxygen transfer limitations in the process. OxyMem does not have any such limitations. OxyMem uses hollow fibre gas permeable membranes to support a fixed film ecosystem for the biology which allows for direct delivery of oxygen to the micro-organisms. OxyMem can achieve 95% oxygen transfer rates which results in superior energy performance (75% saving), lower sludge production (50% less sludge), along with impressive process resilience.

Desalitech, Inc. designs and manufactures advanced industrial reverse osmosis systems for water purification and desalination. The company's flagship product, ReFlex, is versatile and suitable for applications such as pure water supply, boiler feed water, cooling tower makeup, and wastewater reuse. Additionally, the ReFlex Max system addresses brine concentration and seawater desalination needs. Desalitech also offers ReFlex Smart, a software solution for online monitoring and control of its systems. Founded in 2008 by Professor Avi Efraty and originally named Advanced Desalination Technologies, the company focuses on providing efficient water treatment solutions that adapt to varying conditions, reducing operational challenges and costs. Desalitech serves a range of industries, including food and beverage, oil and gas refining, mining, consumer goods, municipal reuse, and power generation, both in the United States and internationally. As of early 2020, Desalitech operates as a subsidiary of DuPont de Nemours, Inc. and is based in Newton, Massachusetts.

Provivi Inc. specializes in developing biopesticides aimed at pest management in agriculture, commercial sectors, households, and public health. The company's innovative approach focuses on using insect pheromones, which provide a safe, environmentally friendly alternative to traditional pesticides. By leveraging biocatalysis technology initially developed at the California Institute of Technology, Provivi enhances the synthesis of these biopesticides, ensuring they are effective and free from toxic residues. Founded in 2013 and based in Santa Monica, California, the company collaborates with distributors worldwide to deliver its products, which are designed to protect food supplies sustainably and affordably. With a team of experienced professionals from biotechnology and the agricultural chemicals industry, Provivi is positioned to transform pest management practices through its advanced biological processes.

FMC Health and Nutrition is a business segment that focuses on producing healthy food and supplements, generating over $700 million in revenue in 2016. The company specializes in two primary areas: texturants used as food ingredients and pharmaceutical excipients. Its product offerings include ingredients such as alginates, carrageenan, and microcrystalline cellulose, which help consumers address specific dietary needs and challenges.

Taxon Biosciences, Inc. is a biotechnology company that specializes in developing innovative applications and products for the agriculture, life sciences, and oil and gas industries. Founded in 2000 and based in Tiburon, California, the company employs advanced microbiology, genomics, and informatics to create solutions that enhance various processes. In the oil and gas sector, Taxon Biosciences develops microbes that improve the extraction of heavy oil and increase the efficiency of coal-to-methane conversion. Additionally, it offers customized microbial solutions for specific biochemical transformations in subsurface environments. In agriculture, the company's products focus on yield optimization and crop protection. Taxon Biosciences also provides assays for propane-utilizing microbes and other tools to aid oil and gas exploration.

Solae™ soy-based ingredient solutions help create nutritious, great-tasting products with a unique combination of functional, nutritional, economical and sustainable benefits.

Innovalight, founded by Conrad Burke, specializes in the development of high-efficiency, low-cost solar modules utilizing innovative silicon-based technology. The company has created a unique silicon ink, which has been in development since 2005, enabling a shift in manufacturing processes by employing liquid-based processing instead of traditional solid or gas methods. This approach aims to significantly enhance the cost-effectiveness and efficiency of solar modules. Innovalight's products are designed for both residential and commercial applications, focusing on ultra thin-film power modules to support grid-connected solar power generation.

MECS is a chemicals firm specializing in phosphate fertilizer, oil refining, and metal smelting industries.

Coastal is a dynamic and creative company.

PsiloQuest develops and commercializes CMP polishing pads for the semiconductor industry.

ChemFirst Inc. produces electronic chemicals and materials to the semiconductor industry and specialty intermediates for polyurethane and other applications

Alien Technology is a provider of reliable, high-volume, low cost, EPC compliant Radio Frequency Identification (RFID) products. Using Fluidic Self Assembly (FSA ), a patented manufacturing process, Alien manufactures electronic product code (EPC) class 1 tags and readers used in a variety of applications including supply chain management, logistics operations and anti-counterfeiting to improve inventory management and reduce operating costs. Alien Technology Corporation is an active member of EPC Global. More information about Alien Technology Corporation can be found on the Company's website at www.alientechnology.com. Alien, Alien Technology and FSA are trademarks or registered trademarks of Alien Technology Corporation in the United States and other countries.

Industria Solutions Inc. is a business-to-business e-commerce company that focuses on the global fluid processing equipment market. The company offers an e-commerce platform that facilitates collaborative engineering, e-procurement, and project and materials management. By leveraging the expertise of its founding companies, Industria Solutions addresses supply chain inefficiencies prevalent in various fluid processing industries, including chemicals, oil and gas, pulp and paper, power generation, and pharmaceuticals. This platform enables clients to streamline their procurement processes and improve operational efficiency.

CombiChem, Inc is a computational drug discovery company that is applying its proprietary design technology and rapid synthesis capabilities to accelerate the discovery process for new drugs. The Company believes its approach offers pharmaceutical and biotechnology companies the opportunity to conduct their drug discovery efforts in a more productive and cost-effective manner. Using its proprietary Discovery Engine(TM) process, the Company focuses on the generation, evolution and optimization of potential new lead candidates for its collaborative partners, who will then develop, manufacture, market and sell any resulting drugs.

Pharmasset Inc is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Their primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus, or HBV, hepatitis C virus, or HCV and human immunodeficiency virus, or HIV. Their research and development efforts focus on a class of compounds known as nucleoside analogs, which act to inhibit the natural enzymes required for viral replication. They are currently focusing on three product candidates, two of which they are developing themselves and one of which they are developing with a strategic partner: • Clevudine, for the treatment of HBV, expected to enter Phase 3 registration clinical trials in the second calendar quarter of 2007; • R7128, a pro-drug of PSI-6130 for the treatment of HCV, in a Phase 1 clinical trial; and • Racivir, for the treatment of HIV, in a Phase 2 clinical trial.